Project Grant HT94252510942
Award Date 9/1/25
Completion Date 8/31/26
Dollars Obligated $811K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- The U.S. Defense Health Agency awarded a $2,175,896 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from June 1, 2025 to June 30, 2029, supports advanced biomedical research to investigate metabolites, metabolic pathways, and the risk of Crohn's disease. As a leading academic medical center and research institution, ISMMS will leverage its expertise in areas such...
- The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
- The Icahn School of Medicine at Mount Sinai has been awarded a $591,486 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, running from September 1, 2023 to August 31, 2026, will support the development of a novel immuno-oncology pipeline for FGFR2 fusion-positive cholangiocarcinoma. The funding will enable the medical school to conduct research aimed at transforming health care for service members and the...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is providing $1,014,000.00 to the Icahn School of Medicine at Mount Sinai to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The research, which is scheduled to take place from September 1, 2024 to August 31, 2028, will leverage the institution's expertise in areas such as cancer biology, immunology, and clinical...
- The Defense Health Agency awarded a $633,750 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) on August 1, 2025 under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research on the "INTERPLAY BETWEEN SENSORY NEURONS AND NK CELLS DURING BREAST CANCER METASTATIC DORMANCY" with a performance period ending on July 31, 2028. As a leading academic medical center, ISMMS has demonstrated extensive capabilities...
- The U.S. Defense Health Agency has awarded a $2,028,000.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY. The grant, awarded on April 1, 2025, supports research to identify epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer. As a leading academic medical research institution, ISMMS has demonstrated extensive capabilities in conducting...
- The Defense Health Agency awarded the Icahn School of Medicine at Mount Sinai a $3,300,817.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will leverage personalized stem cell therapy to overcome airway reconstruction challenges. The research will be conducted in New York, NY and is expected to be completed by May 31, 2029. The Icahn School of Medicine at Mount Sinai is a prominent academic medical center and research institution known for...
- The Icahn School of Medicine at Mount Sinai will receive $1,521,002 under a three-year Project Grant award from the Defense Health Agency. The grant will support research from August 1, 2023 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). Specifically, the funding will enable research to determine the contribution of lineage intermediate tumor cells during progression to T-SCNC. This work aligns with the Military Medical Research and Development...
- This $949,181 federal Project Grant award was provided by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research by the Icahn School of Medicine at Mount Sinai to investigate the association between cortical lesions and physical/cognitive disability in multiple sclerosis using novel, clinically feasible MRI methods. The research aims to advance the understanding and treatment of multiple sclerosis, a...
- This federal Project Grant award of $202,800 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York. The award is focused on "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis" and will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award...